Innovation and Sustainability

Keyphrases

1. Netherlands 100%
2. Dutch 97%
3. Europe 86%
4. Sustainability Transitions 72%
5. Responsible Innovation 70%
6. European Union 57%
7. Drug Development 50%
8. Aging 48%
9. Innovation Systems 48%
10. Artemisinin-based Combination Therapy 44%
11. Alzheimer's Disease 41%
12. Advanced Therapy Medicinal Products 41%
13. Business Model 35%
14. Cell-based 34%
15. Innovation Policy 34%
16. Biopharmaceuticals 33%
17. Gene Therapy 33%
18. Politicians 33%
19. Older People 32%
20. Market Formation 30%
21. Artificial Intelligence 28%
22. Circular Economy 28%
23. Marketing Authorization 28%
24. Conditional Marketing Authorization 28%
25. Health Technology Assessment 28%
26. Sustainable Development Goals 27%
27. Potato Breeding 26%
28. Health Technology 25%
29. Co-creation 24%
30. Innovation Process 24%
31. Africa 24%
32. Co-constitution 24%
33. United States 23%
34. Carsharing 22%
35. Transition Studies 21%
36. Germany 21%
37. Coverage Decisions 20%
38. Sustainable Public Procurement 20%
39. Corporate Sustainability Integration 20%
40. Health Innovation 20%
41. Indonesia 19%
42. Socio-technical Transitions 19%
43. Sustainability Challenges 19%
44. System Building 19%
45. Technology Studies 18%
46. Smallholder Farmers 18%
47. Corporate Sustainability 18%
48. Health Insurance Coverage 18%
49. Health Systems 17%
50. Science Studies 17%
51. Meat 17%
52. Developing Countries 17%
53. Pharmaceutical Industry 17%
54. Long-term Care 16%
55. Reimbursement 16%
56. Technological Innovation System 16%
57. Earth-space 16%
58. Technological Innovation 16%
59. Adverse Drug Reaction 16%
60. Social Innovation 16%
61. Politics 15%
62. Periodic Safety Update Report 15%
63. Monoclonal Antibody 15%
64. Nonhuman Primate 15%
65. Self-management 15%
66. Open Innovation 15%
67. Post-approval Changes 15%
68. Nanotechnology 15%
69. Hybrid Potato 15%
70. Gene Editing 15%
71. Post-authorization 15%
72. Patient Engagement 15%
73. Orphan Drugs 15%
74. Digital Innovation 15%
75. Pharmaceutical Companies 15%
76. Aging in Place 14%
77. Grand Challenges 14%
78. Regulatory Actions 14%
79. Agriculture 14%
80. Entrepreneurship 14%
81. Pharmacogenomics 14%
82. Older Persons 14%
83. Safety Assessment 13%
84. Leasing 13%
85. Structured Interview 13%
86. Medicinal Product Development 13%
87. Healthcare 13%
88. Pharmaceutical Innovation 13%
89. Institutional Work 13%
90. Ridesharing 13%
91. Intermediary Actors 13%
92. Regulatory Agencies 12%
93. Societal Challenges 12%
94. Malaria 12%
95. Societal Impacts 12%
96. Older Adults 12%
97. Utrecht 12%
98. Scientific Innovation 12%
99. Biotechnology 12%
100. Innovation Path 12%